Whole Genome DNA Methylation and Genotyping for SL

Closed Solicitation Posted

Solicitation number
75N92024Q1066
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

More information

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute is seeking proposals for Whole Genome DNA Methylation and Genotyping services for SLE (systemic lupus erythematosus) patients. The key objectives are to conduct DNA methylation and genotyping analysis on whole genome samples from SLE patients. The evaluation will focus on the contractor's technical approach, relevant expertise and experience, and overall cost-effectiveness. Proposals are due by August 7, 2024, with no set-aside designation indicated.

This is the third phase of this research initiative. There is no information provided on potential incumbent contractors or award value ranges. The solicitation indicates this is a federal civilian agency requirement, with the work to be performed at the contractor's facility under the NAICS code for Colleges, Universities, and Professional Schools.

Notice text

Whole Genome DNA Methylation and Genotyping for SLE patients – Third Phase

Similar open opportunities

Opportunity Agency Set-aside Responses due
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
Clinical Research Support and Collaboration for NHGRI Protocols Bethesda, Maryland, United States · NAICS 541690 Office of Logisitics and Acquisition Operations Total Small Business
RNA sequencing and whole genome sequencing services Bethesda, Maryland 20892, United States · NAICS 32599 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors